Bioinformatic Analysis of Hepatocellular Carcinoma Cell Lines to the Efficacy of Nimotuzumab

References

• Balabaud C, Bioulac-Sage P, Ferrell L, et al. Well-differentiated hepatocellular neoplasm of uncertain malignant potential. Hum Pathol. 2015;46(4):634–635. doi:10.1016/j.humpath.2014.10.029
   PubMed Web of Science ®Google Scholar
• Globocan. Estimated number of new cases in 2020. Available from https://gco.iarc.fr/today/online-analysis-table. Accessed January 17, 2021.
   Google Scholar
• Globocan. Estimated number of deaths in 2020. Available from https://gco.iarc.fr/today/online-analysis-table. Accessed January 17, 2021.
   Google Scholar
• Chen JG, Zhang SW. Liver cancer epidemic in china: past, present and future. Semin Cancer Biol. 2011;21(1):59–69. doi:10.1016/j.semcancer.2010.11.002
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network: Nccn clinical practice guidelines in oncology. Hepatobiliary cancers, version 1; 2020. Available from https://www.nccn.org/professionals/physician_gls/default.aspx. Accessed March 23, 2020.
   Google Scholar
• Chinese Society of Clinical Oncology. Guidelines of chinese society of clinical oncology (csco). Hepatocellular carcinoma; 2020.V1. Available from http://www.csco.org.cn/cn/index.aspx. Accessed July 18, 2020.
   Google Scholar
• Zaczek A, Brandt B, Bielawski KP. The diverse signaling network of egfr, her2, her3 and her4 tyrosine kinase receptors and the consequences for therapeutic approaches. Histol Histopathol. 2005;20(3):1005–1015. doi:10.14670/HH-20.1005
   PubMed Web of Science ®Google Scholar
• Baselga J. Why the epidermal growth factor receptor? The rationale for cancer therapy. Oncologist. 2002;7(Suppl 4):2–8. doi:10.1634/theoncologist.7-suppl_4-2
   PubMed Web of Science ®Google Scholar
• Daveau M, Scotte M, Francois A, et al. Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma. Mol Carcinog. 2003;36(3):130–141. doi:10.1002/mc.10103
   PubMed Web of Science ®Google Scholar
• Chiorean EG, Ramasubbaiah R, Yu M, et al. Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: hoosier oncology group gi06-101. Oncologist. 2012;17(1):13. doi:10.1634/theoncologist.2011-0253
   PubMed Web of Science ®Google Scholar
• Llovet JM, Bruix J. Molecular targeted therapies in hepatocellular carcinoma. Hepatology. 2008;48(4):1312–1327. doi:10.1002/hep.22506
   PubMed Web of Science ®Google Scholar
• Zhu AX, Stuart K, Blaszkowsky LS, et al. Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma. Cancer. 2007;110(3):581–589. doi:10.1002/cncr.22829
   PubMed Web of Science ®Google Scholar
• Lin XM, Hu L, Gu J, et al. Choline kinase alpha mediates interactions between the epidermal growth factor receptor and mechanistic target of rapamycin complex 2 in hepatocellular carcinoma cells to promote drug resistance and xenograft tumor progression. Gastroenterology. 2017;152(5):1187–1202. doi:10.1053/j.gastro.2016.12.033
   PubMed Web of Science ®Google Scholar
• Zhang G, Li X, Chen Q, et al. Cd317 activates egfr by regulating its association with lipid rafts. Cancer Res. 2019;79(9):2220–2231. doi:10.1158/0008-5472.Can-18-2603
   PubMed Web of Science ®Google Scholar
• Crombet-Ramos T, Rak J, Perez R, Viloria-Petit A. Antiproliferative, antiangiogenic and proapoptotic activity of h-r3: a humanized anti-egfr antibody. Int J Cancer. 2002;101(6):567–575. doi:10.1002/ijc.10647
   PubMed Web of Science ®Google Scholar
• Ramakrishnan MS, Eswaraiah A, Crombet T, Piedra P, Saurez G, Iyer H, Arvind AS. Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin. MAbs. 2009;1(1):41–48. doi:10.4161/mabs.1.1.7509
   PubMed Web of Science ®Google Scholar
• Reddy BK, Lokesh V, Vidyasagar MS, et al. Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: a randomized, open-label, phase iib, 5-year study in indian patients. Oral Oncol. 2014;50(5):498–505. doi:10.1016/j.oraloncology.2013.11.008
   PubMed Web of Science ®Google Scholar
• Strumberg D, Schultheis B, Scheulen ME, et al. Phase ii study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (egfr) antibody, in patients with locally advanced or metastatic pancreatic cancer. Invest New Drugs. 2012;30(3):1138–1143. doi:10.1007/s10637-010-9619-8
   PubMed Web of Science ®Google Scholar
• Song P, Yang J, Li X, et al. Hepatocellular carcinoma treated with anti-epidermal growth factor receptor antibody nimotuzumab: a case report. Medicine (Baltimore). 2017;96(39):e8122. doi:10.1097/md.0000000000008122
   PubMed Web of Science ®Google Scholar
• Chen S, Zhou Y, Chen Y, Gu J. Fastp: an ultra-fast all-in-one fastq preprocessor. Bioinformatics. 2018;34(17):i884–i890. doi:10.1093/bioinformatics/bty560
   PubMed Web of Science ®Google Scholar
• Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with hisat2 and hisat-genotype. Nat Biotechnol. 2019;37(8):907–915. doi:10.1038/s41587-019-0201-4
   PubMed Web of Science ®Google Scholar
• Pertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT, Salzberg SL. Stringtie enables improved reconstruction of a transcriptome from rna-seq reads. Nat Biotechnol. 2015;33(3):290–295. doi:10.1038/nbt.3122
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for rna-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi:10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet. 2000;25(1):25–29. doi:10.1038/75556
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. Kegg: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353–D361. doi:10.1093/nar/gkw1092
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, He QY. Clusterprofiler: an r package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287. doi:10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP. Gsea-p: a desktop application for gene set enrichment analysis. Bioinformatics. 2007;23(23):3251–3253. doi:10.1093/bioinformatics/btm369
   PubMed Web of Science ®Google Scholar
• Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP. Molecular signatures database (msigdb) 3.0. Bioinformatics. 2011;27(12):1739–1740. doi:10.1093/bioinformatics/btr260
   PubMed Web of Science ®Google Scholar
• Hoshida Y, Nijman SM, Kobayashi M, et al. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res. 2009;69(18):7385–7392. doi:10.1158/0008-5472.CAN-09-1089
   PubMed Web of Science ®Google Scholar
• Kira S, Nakanishi T, Suemori S, Kitamoto M, Watanabe Y, Kajiyama G. Expression of transforming growth factor alpha and epidermal growth factor receptor in human hepatocellular carcinoma. Liver. 1997;17(4):177–182. doi:10.1111/j.1600-0676.1997.tb00803.x
   PubMedGoogle Scholar
• Ito Y, Takeda T, Sakon M, et al. Expression and clinical significance of erb-b receptor family in hepatocellular carcinoma. Br J Cancer. 2001;84(10):1377–1383. doi:10.1054/bjoc.2000.1580
   PubMed Web of Science ®Google Scholar
• Kannangai R, Sahin F, Torbenson MS. Egfr is phosphorylated at ty845 in hepatocellular carcinoma. Mod Pathol. 2006;19(11):1456–1461. doi:10.1038/modpathol.3800665
   PubMed Web of Science ®Google Scholar
• Zhu W, Qin L. Golm1-regulated egfr/rtk recycling is a novel target for combating hcc metastasis. Sci China Life Sci. 2017;60(1):98–101. doi:10.1007/s11427-016-0311-x
   PubMed Web of Science ®Google Scholar
• Liang Y, Peng J, Li N, et al. Smart nanoparticles assembled by endogenous molecules for sirna delivery and cancer therapy via cd44 and egfr dual-targeting. Nanomedicine. 2019;15(1):208–217. doi:10.1016/j.nano.2018.09.018
   PubMed Web of Science ®Google Scholar
• Li WY, Li Q, Jing L, et al. P57-mediated autophagy promotes the efficacy of egfr inhibitors in hepatocellular carcinoma. Liver Int. 2019;39(1):147–157. doi:10.1111/liv.13957
   PubMed Web of Science ®Google Scholar
• Buckley AF, Burgart LJ, Sahai V, Kakar S. Epidermal growth factor receptor expression and gene copy number in conventional hepatocellular carcinoma. Am J Clin Pathol. 2008;129(2):245–251. doi:10.1309/WF10QAAED3PP93BH
   PubMed Web of Science ®Google Scholar
• Yamaguchi K, Bi C, Ma N. Concomitant and isolated expression of tgf-alpha and egf-r in human hepatoma cells supports the hypothesis of autocrine, paracrine, and endocrine growth of human hepatoma. J Surg Oncol. 1995;58(4):240–245. doi:10.1002/jso.2930580409
   PubMed Web of Science ®Google Scholar
• Baselga J, Gomez P, Greil R, et al. Randomized phase ii study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer. J Clin Oncol. 2013;31(20):2586–2592. doi:10.1200/JCO.2012.46.2408
   PubMed Web of Science ®Google Scholar
• Paul MD, Hristova K. The rtk interactome: overview and perspective on rtk heterointeractions. Chem Rev. 2019;119(9):5881–5921. doi:10.1021/acs.chemrev.8b00467
   PubMed Web of Science ®Google Scholar
• Affo S, Yu LX, Schwabe RF. The role of cancer-associated fibroblasts and fibrosis in liver cancer. Annu Rev Pathol. 2017;12(1):153–186. doi:10.1146/annurev-pathol-052016-100322
   PubMed Web of Science ®Google Scholar
• Wu S, Zheng Q, Xing X, et al. Matrix stiffness-upregulated loxl2 promotes fibronectin production, mmp9 and cxcl12 expression and bmdcs recruitment to assist pre-metastatic niche formation. J Exp Clin Cancer Res. 2018;37(1):99. doi:10.1186/s13046-018-0761-z
   PubMed Web of Science ®Google Scholar
• Liu G, Yin L, Ouyang X, Zeng K, Xiao Y, Li Y. M2 macrophages promote hcc cells invasion and migration via mir-149-5p/mmp9 signaling. J Cancer. 2020;11(5):1277–1287. doi:10.7150/jca.35444
   PubMed Web of Science ®Google Scholar
• Zhou Y, Ren H, Dai B, et al. Hepatocellular carcinoma-derived exosomal mirna-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts. J Exp Clin Cancer Res. 2018;37(1):324. doi:10.1186/s13046-018-0965-2
   PubMed Web of Science ®Google Scholar